Quipt Home Medical Receives Final Order Approving Arrangement

Core Viewpoint - Quipt Home Medical Corp. is set to be acquired by affiliates of Kingswood Capital Management and Forager Capital Management for US$3.65 per share, with the final court approval received for the arrangement, expected to close by March 16, 2026 [1]. Group 1: Acquisition Details - The Supreme Court of British Columbia issued a final order approving the acquisition plan under the Business Corporations Act [1]. - The cash consideration for the acquisition is US$3.65 per share [1]. - The completion of the arrangement is anticipated by March 16, 2026, assuming all conditions are met [1]. Group 2: Delisting and Reporting Status - Following the completion of the arrangement, the shares of Quipt Home Medical Corp. will be delisted from both the Toronto Stock Exchange and Nasdaq [2]. - The company will cease to be a reporting issuer in all jurisdictions where it currently reports under applicable securities laws [2]. Group 3: Company Overview - Quipt Home Medical Corp. specializes in in-home monitoring and disease management services, particularly focusing on respiratory care solutions for patients in the U.S. healthcare market [4]. - The company aims to expand its service offerings to manage various chronic diseases, including heart and pulmonary diseases, sleep disorders, and reduced mobility [4]. - The primary business objective is to provide a broader range of services for patients requiring in-home monitoring and chronic disease management [4].